Table 3.
Distribution of best response for different kinds of sarcoma histology
| CR | PR | SD | PD | na | |
|---|---|---|---|---|---|
| Soft tissue sarcomaa (n = 88) | 19 (22 %) | 17 (19%) | 42 (48 %) | 9 (10 %) | 1 (1 %) |
| Uterine sarcoma (n = 17) | 12 (71 %) | 4 (24%) | – | 1 (6 %) | – |
| Osteosarcoma (n = 16) | 3 (19 %) | – | 9 (56 %) | 4 (25 %) | – |
| Ewing/PNETb (n = 14) | 4 (29 %) | 6 (43%) | 2 (14 %) | 2 (14 %) | – |
| Nerve-derivated sarcoma (n = 1) | 1 (100 %) | – | – | – | – |
aLeiomyosarcoma, synovial sarcoma, liposarcoma, malignant fibrous histocytoma (MFH), angiosarcoma, fibrosarcoma, pleomorf sarcoma and unspecified soft tissue sarcoma
bPrimary neuroectodermal tumour (PNET)